Bristol-Myers Squibb renews contract with Cegedim Dendrite

Pursuant to the terms of contract, Bristol-Myers will implement Mobile Intelligence, Cegedim’s customer relationship management (CRM) solution, to its neurosciences sales team. The new agreement also includes the continuance of data and technical support on its current CRM tool.

According to Cegedim, Mobile Intelligence has been designed to improve the workflow of all types of customer facing work forces within pharmaceutical and biotech companies. It uses human-centered design principles and provides a single view of the customer, empowering collaboration, fostering communication and enhancing visibility across disciplines.

Laurent Schockmel, COO of Cegedim Americas, said: “We are committed to helping Bristol-Myers Squibb achieve their growth goals. Our solutions and services are pharmaceutical by design and not a byproduct of part-time focus or adaptations of horizontal sales force automation tools.

“This enables Cegedim Dendrite to provide solutions that fit and reflect the actual workflow of pharmaceutical managers, thereby yielding productivity improvements while minimizing administrative tasks.”